Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Charles River Laboratories
CRO
Charles River sells CDMO and discovery assets in strategic pivot
The CRO is offloading its contract manufacturing operation and some of its European discovery services, which brought in $287 million last year.
Darren Incorvaia
Feb 25, 2026 1:54pm
Charles River to close Maryland CDMO site, lay off 20 staffers
Feb 3, 2026 12:20pm
Charles River inks $510M deal to bring primate supply in-house
Jan 14, 2026 10:45am
Longtime Charles River CEO to retire; COO will take the helm
Jan 8, 2026 12:54pm
Charles River lays off 70 staffers as strategic shift begins
Nov 14, 2025 4:40pm
Charles River to cut costs, shift direction as revenue slides
Nov 5, 2025 12:54pm
